dr. balar on pd-l1 testing for urothelial cancer
Published 7 years ago • 88 plays • Length 1:08Download video MP4
Download video MP3
Similar videos
-
3:32
value of pd-l1 testing in metastatic urothelial cancer
-
0:47
dr. balar on combinations with pembrolizumab for urothelial cancer
-
0:54
dr. o’donnell on challenges with pd-l1 testing in bladder cancer
-
1:21
dr. o’donnell on pd-l1 testing in bladder cancer
-
7:55
pd-l1 expression in bladder cancer
-
1:52
dr. balar on immunotherapy treatment in bladder cancer
-
0:51
dr. balar on the approval of pembrolizumab for bladder cancer
-
1:25
dr. balar on imvigor 210 results for metastatic urothelial carcinoma
-
0:54
dr. balar on results of keynote-052 in urothelial cancer
-
1:12
dr. sharma on pd-l1 as biomarker for immunotherapy in bladder cancer
-
1:57
dr. balar on remaining questions with immunotherapy in bladder cancer
-
0:48
dr. balar on the future of immunotherapy in bladder cancer
-
1:09
dr. balar on improved outlook in metastatic bladder cancer
-
1:32
dr. balar discusses study of immunotherapy combination in bladder cancer
-
0:54
dr. balar on biomarkers of immunotherapy response in bladder cancer
-
34:39
bladder cancer and immunotherapy with dr. arjun balar
-
1:30
dr. bellmunt on pd-l1 data in bladder cancer
-
1:57
dr. balar on mature clinical results of keynote-052 in urothelial cancer
-
1:07
dr. balar on impact of durvalumab plus tremelimumab in bladder cancer